The cannabis industry has managed to continue growing with a massive amount of ferocity toward the future, but new updates have helped to make this move even faster than anyone thought possible. As we move toward the next few years of the industry, it seems as though several players have come to the forefront and have seen massive success. Because of this, several stocks have become key players throughout the market, and here are just a few.
The first stock on the list and one that should come as no surprise is the company Aphria (NASDAQOTH: APHQF). Aphria has been considered to be one of the largest domestic growers of cannabis in all of Canada and has for some time, been able to maintain this large amount of growth. The company also made headlines as the only company in its market to be able to post 11 consecutive quarters of positive EBITDA. Aphria has several things going for it that make it quite a top choice in the world of cannabis investing. Aphria has for one, been able to up their production by a massive amount, with expectations to grow as much as 255,000 kilograms of cannabis by the end of next year. This means that they could potentially become the largest domestic grower of cannabis in the nation as we move toward the neat future.
One of the best opportunities that Aphria has seen is the addition of the possibility of joining the international cannabis market. Many companies in the space have been working to expand their operations into markets such as that of Germany and beyond. Because of this, any fear of overproduction has been heavily mitigated due to the potential for exportation of excess products.
The next company on the list is the company MariMed (NASDAQOTH:MRMD). MariMed has quickly become one of the larger players in the U.S. market with many services being offered to the cannabis industry. The company according to one report “provides professional management services to marijuana growers. These services range from helping customers obtain cannabis cultivation licenses to managing their growing facilities to providing legal and administrative services. In addition, MariMed markets its own lineup of marijuana products. These cannabis-infused products include MariMints mints, Kalm-Corn popcorn, and Betty’s Eddies fruit chews.” The company currently operates out of six facilities that are spaced across four states in the U.S. With so much exposure to the cannabis market, it seems as though MariMed may be one of the better choices for investors to take a look at.
The last company on the list is the company Marapharm Ventures (MRPHF). According to one report, “Marapharm Ventures Inc., a development stage medical marijuana company, focuses on operating in the medical and recreational marijuana industry in Canada and the United States. The company has market cap of $24.51 million. The firm was formerly known as Capital Auction Market Inc. and changed its name to Marapharm Ventures Inc. in August 2014. It currently has negative earnings. Marapharm Ventures Inc. was incorporated in 2007 and is headquartered in Kelowna, Canada. Because of their access to the extensive and growing cannabis market in Canada, it seems as though they are perfectly positioned to take advantage of the growing cannabis market domestically.
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Marapharm Ventures, Midam has been paid $200,000 from the company and ZERO shares of Marapharm Ventures Inc. for a duration beginning June 27, 2018 and ending July 27, 2018. We may buy or sell additional shares of (MRPHF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.